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Multifunctional Eu-doped NaGd(MoO4)2
nanoparticles functionalized with poly(L-lysine)
for optical and MRI imaging†
Mariano Laguna,a Nuria O. Nuñez,*a Verónica Rodríguez,a Eugenio Cantelar,b
Grazyna Stepien,c María Luisa García,d Jesús M. de la Fuentee and Manuel Ocañaa
A method for the synthesis of non-aggregated and highly uniform Eu3+ doped NaGd(MoO4)2 nano-
particles is reported for the ﬁrst time. The obtained particles present tetragonal structure, ellipsoidal
shape and their size can be varied by adjusting the experimental synthesis parameters. These nano-
particles, which were coated with citrate anions and functionalised with PLL, have also been developed in
order to improve their colloidal stability in physiological medium (2-(N-morpholino)ethanesulfonic acid,
MES). A study of the luminescent dynamics of the samples as a function of the Eu doping level has been
conducted in order to ﬁnd the optimum nanophosphors, whose magnetic relaxivity and cell viability have
also been evaluated for the ﬁrst time for this system, in order to assess their suitability as multifunctional
probes for optical (in vitro) and magnetic bioimaging applications.
1. Introduction
Luminescent materials based on rare-earth (RE) compounds,
consisting of a crystalline host doped with a small amount of
lanthanide (Ln) cations, have recently attracted much attention
because of their important applications in several fields of
science and technology. Of particular interest is their use in
many biotechnological applications including biosensing and
biological imaging,1,2 to mention a few. Such interest mainly
arises from the lower toxicity and higher chemical and optical
stability of these phosphors when compared with other lumine-
scent materials (quantum dots, organic dye-based systems, etc.).
The luminescent characteristics of this kind of material are
determined by the nature of the doping cations. Thus, down
conversion (emissions at lower energy than that of excitation)
or up-conversion (emissions at higher energy than that of exci-
tation) phosphors can be obtained by a suitable selection of
the emitting cations. In the former case, the most appropriate
Ln doping cations emitting in the visible region for bio-
applications are Eu3+, whose most intense emissions lie in the
red region, where the auto-fluorescence of tissues is mini-
mized in this wavelength range.3 It is also important to
mention that the presence of Gd3+ cations in these phosphors
is also of high interest due to the large magnetic moment and
nanosecond scale electronic relaxation time of these cations,
which confers to such materials an additional functionality as
contrast agents for magnetic resonance imaging (MRI).4
For most biotechnological applications, the size and shape
of these multifunctional materials are very important para-
meters to be controlled since such characteristics aﬀect some
physical properties, including luminescence and magnetic
relaxivity5 and, consequently, their performance for optical
and magnetic imaging. Particle size has also a strong influence
on other important processes involved in their in vivo appli-
cations such as the circulation behaviour of nanoparticles in
the body, their biodistribution and excretion pathway.6 In
addition, such nanoparticles must be obviously non-toxic and
present high colloidal stability in physiological media. To
meet the latter criteria, the modification of the nanoparticle
surface with ligands having diﬀerent functional groups (car-
boxylate, amino, imino, etc.) is usually required, which helps
to achieve a high colloidal stability of the nanoparticles by
increasing the surface charge or by steric hindrance7 and also
provides anchors for the further bioconjugation of the nano-
particles with molecules of biological interest.8 Several organic
polymers have been tested for the functionalization of nano-
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particles including poly(L-lysine) (PLL), a positively charged
amino acid polymer having both the amine (–NH2) and car-
boxylic acid (–COOH) groups. This polymer oﬀers several
advantages, such as good biocompatibility, relatively good
solubility in water and plentiful active amino groups,9 which
makes it very interesting for the development of carriers for
gene delivery.10 It has also been shown that materials with
high levels of positive charge are capable of conferring anti-
microbial properties because these cationic species are able to
disrupt bacterial membranes.11,12
A large variety of RE-based compounds have been con-
sidered as a host matrix, including oxides,13 phosphates,14
vanadates,15 and fluorides.16 Molybdate compounds have also
been shown to be very advantageous hosts due to their ability
to absorb energy in the UV region and further transfer such
energy to some Ln3+ cations, which considerably increases the
intensity of their emissions.17 However, to the best of our
knowledge, very little attention has been paid to these systems,
including those systems based on NaGd(MoO4)2, which are of
special interest owing to their additional magnetic imaging
capability associated with the Gd ions. The main reason might
be the scarce number of methods for the synthesis of nano-
particles of RE molybdate materials available in the literature.
In fact, to our knowledge, the synthesis of uniform
NaGd(MoO4)2 nanoparticles, either undoped or doped with Ln
cations, has not been yet achieved.
Herein, we report for the first time in the literature a
method for the synthesis of non-aggregated and highly
uniform Eu3+ doped NaGd(MoO4)2 nanoparticles with a tetra-
gonal structure, which are surface-modified with citrate
anions. This procedure, based on a homogeneous precipi-
tation process in a polyol-based medium, has been shown to
be quite suitable to obtain nanoparticles of several RE-based
compounds18–20 due to the ability of these alcohols to limit
particle growth. The obtained particles present ellipsoidal
shape and their size can be varied by adjusting the experi-
mental synthesis parameters. A procedure for the further
functionalization of these nanophosphors with PLL has also
been developed in order to improve their colloidal stability in
physiological medium (2-(N-morpholino)ethanesulfonic acid,
MES). A study of the luminescent dynamics of the samples as
a function of the Eu doping level has been conducted in order
to find the optimum nanophosphors, whose magnetic relaxiv-
ity and cell viability have also been evaluated for the first time
for this system, in order to assess their suitability as multifunc-
tional probes for optical and magnetic bioimaging
applications.
2. Experimental details
2.1. Materials
Gadolinium(III) nitrate hexahydrate (GdNO3·6H2O, Aldrich,
99.9%) and europium(III) nitrate pentahydrate (Eu(NO3)3·5H2O,
Aldrich, 99.9%) were selected as Ln precursors and sodium
molybdate (Na2MoO4, Aldrich, ≥98%) was used as the molyb-
date source. Sodium citrate (Na3C6O7H5·2H2O, Aldrich, 99.5%)
was also needed as a complexing agent whereas ethylene
glycol (EG, Aldrich, ≥99.5%)–water (Milli-Q) mixtures were
used as solvents. For the functionalization of the nanoparticles
with poly(L-lysine) (PLL), a solution 0.1% w/v in water from
Aldrich was used. Sodium hydroxide (NaOH, Aldrich, BioXtra,
≥98%) was used to adjust pH.
2.2. Synthesis of NaGd(MoO4)2 nanoparticles
The synthesis of NaGd(MoO4)2 nanoparticles was carried out
under diﬀerent experimental conditions, which are detailed in
Table 1. The experimental procedure was as follows. The
required amounts of Gd(NO3)3 and sodium citrate were dis-
solved in ethylene glycol (2.5 cm−3) under magnetic stirring
while heating the vial at ∼80 °C to facilitate the dissolution
process. The resulting solution was left to cool down to room
temperature. In a separate vial, the desired amount of
Na2MoO4 was dissolved in a certain volume of Milli-Q water
(from 1 to 1.5 cm3) and then ethylene glycol was added to this
aqueous solution until completing 2.5 cm3 of mixture. The
latter was then added to the solution containing the Ln–citrate
complex, under magnetic stirring, and the mixture was quickly
Table 1 Shape and size (longest × shorter dimensions) of the nanoparticles obtained by heating for 20 h at diﬀerent temperatures (T ), solutions
with variable concentration of Gd(NO3)3, Na2MoO4 and citrate ions, using EG : H2O mixtures as solvent. The standard deviations (SD) are shown in
parentheses
[Gd(NO3)3]
mol dm−3
[Na2MoO4]
mol dm−3
MoO4
2−/Gd3+
(mol ratio)
EG : H2O
v/v (ml) T (°C)
Citrate/Gd3+
(mol ratio) Particle shape
Particle size/
TEM (nm)
0.02 0.1 5 4 : 1 120 — Aggregated spheroids —
0.02 0.1 5 4 : 1 120 1 Irregular —
0.02 0.1 5 4 : 1 120 2 Ellipsoidal 120(10) × 60(6)
0.02 0.1 5 4 : 1 120 5 No precipitation —
0.01 0.05 5 4 : 1 120 2 No precipitation —
0.04 0.2 5 4 : 1 120 2 Aggregated ovoids —
0.02 0.1 5 4 : 1 80 2 No precipitation —
0.02 0.1 5 4 : 1 150 2 Irregular —
0.02 0.1 5 5 : 0 120 2 No precipitation —
0.02 0.1 5 3.5 : 1.5 120 2 Ellipsoidal 265(12) × 140(8)
0.05 0.1 2 4 : 1 120 2 Ellipsoidal 70(5) × 35(6)
0.02 0.04 2 4 : 1 120 2 No precipitation —
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introduced into an oven preheated at the desired temperature,
in which it was finally aged for 20 h in tightly closed test
tubes. After aging, the resulting dispersions were cooled down
to room temperature, centrifuged to remove the supernatants,
the precipitates were washed twice with ethanol and finally dis-
persed in Milli-Q water. For some analyses, the powders were
dried at room temperature.
2.3. Synthesis of Eu-doped NaGd(MoO4)2 nanoparticles
For the synthesis of Eu-doped NaGd(MoO4)2 nanoparticles, we
proceeded as described above for the case of the undoped
system but incorporating the desired amount of Eu to the
starting Gd(NO3)3 solution. The Eu/(Eu + Gd) molar ratio was
varied from 2 to 15% in order to investigate the eﬀect of this
doping level on the luminescent properties of the precipitated
nanoparticles.
For cytotoxicity assays, the pristine Eu-doped NaGd(MoO4)2
nanoparticles were previously sterilized by filtration through a
0.2 μm Millipore filter.
2.4. Functionalization with poly(L-lysine)
For functionalization, poly(L-lysine) solutions (0.1 mg mL−3)
were prepared with thepH adjusted to 10 by the addition of
NaOH. A weighted amount of the Eu-doped NaGd(MoO4)2
nanoparticles previously synthesized was added to such solu-
tions so that their final concentration was 0.2 mg mL−1. The
resulting dispersions, with a total volume of 10 mL, were main-
tained under magnetic stirring for 1 h. After this treatment,
the so functionalized nanoparticles were washed several times
with distilled water by centrifugation and finally redispersed
in Milli-Q water.
For the in vitro toxicity studies, the synthesized nanopho-
sphors were first autoclaved at 120 °C per bar and then func-
tionalized under sterile conditions in a laminar flow hood
according to the protocol described above. The autoclavation
process did not have influence on nanoparticle morphology
nor stability (data not shown).
2.5. Characterization
The shape of the nanoparticles was examined by transmission
electron microscopy (TEM, Philips 200CM). For this, a droplet
of an aqueous suspension of the samples was deposited on a
copper grid coated with a transparent polymer and dried. The
particle size distributions were obtained from the micrographs
by counting about one hundred particles, as well as by
dynamic light scattering (DLS) measurements conducted using
a Malvern Zetasizer Nano-ZS90 apparatus. The same equip-
ment was employed to obtain Z potential values. The colloidal
stability of nanoparticle suspensions (nanoparticle concen-
tration = 0.5 mg mL−3) in milliQ water at pH 6.8 and in 50 mM
MES solutions at pH 6.5, was monitored by analyzing the par-
ticle size distribution (hydrodynamic diameter, dh) obtained
from dynamic light scattering (DLS) measurements (Zetasizer
NanoZS90, Malvern). The quantitative composition of the
samples was analyzed by inductively coupled plasma atomic
emission spectroscopy (ICP-AES, Horiba Jobin Yvon, Ultima 2).
The crystalline structure of the prepared nanoparticles was
identified by X-ray diﬀraction (XRD, Panalytical X’Pert Pro with
an X-Celerator detector). The XRD data were collected at inter-
vals of 0.02° (2θ) and an accumulation time of 4000 s. The
infrared spectra (FTIR) of the nanoparticles diluted in KBr
pellets were recorded in a Jasco FT/IR-6200 Fourier transform
spectrometer. Thermogravimetric analyses (TGA) were per-
formed in air at a heating rate of 10 °C min−1, using a Q600 TA
Instrument.
For an appropriate comparison of the luminescent pro-
perties of these nanophosphors containing diﬀerent Eu
doping levels, aqueous suspensions of the samples having the
same concentration (0.5 mg cm−3) were prepared. The exci-
tation and emission spectra of these dispersed samples were
measured in a Horiba Jobin Yvon spectrofluorimeter
(Fluorolog FL3-11) operating with a slit of 1.5 nm. Both spectra
were corrected by the spectral response of the equipment and
the intensity of the excitation source. The lifetime measure-
ments for the Eu-doped nanophosphors were obtained for
powdered samples under pulsed excitation at 532 nm by using
the second harmonic of a Nd:YAG laser (Spectra Physics model
DCR 2/2A 3378) with a pulse width of 10 ns and a repetition
rate of 10 Hz. The fluorescence was analysed through an ARC
monochromator model SpectraPro 500-i and then detected
synchronously with an EMI-9558QB photomultiplier and
recorded by a Tektronix TDS420 digital oscilloscope. The
photograph showing the luminescence of the aqueous suspen-
sion of the Eu-doped nanophosphors was taken under illumi-
nation with ultraviolet radiation (λ = 312 nm).
1H NMR relaxation times T1 and T2 were measured at 1.5 T
in a Relaxiometer (Bruker Minispec spectrometer) at diﬀerent
concentrations of nanoparticles in water at 298 K. Aqueous
solutions of nanoparticles at concentrations ranging from
0.01 mM to 0.2 mM in Gd as determined by Plasma ICP
(ICP-AES, Horiba Jobin Yvon, Ultima 2) were prepared and
transferred into an 8-well chamber (Ibidi, Martinsried,
Germany). T1 values were determined using a saturation-recov-
ery spin-echo sequence (TR values from 50 ms to 10 s) and T2
values using a 64-echo Carr-Purcell-Maiboom-Gill (CPMG)
sequence (TE values from 7.5 ms to 640 ms). Relaxivities
(r1, r2) were obtained from the slopes of the curves 1/T1 or 2 vs.
the concentration of Gd(III) expressed in mM. T1 and T2 relaxiv-
ities were also measured at high field (9.4 T) on a Bruker
Biospec MRI system equipped with 400 mT m−1 field gradients
and a 40 mm quadrature bird-cage resonator at 298 K.
Phantoms were obtained at 9.4 Tesla in a BrukerBiospec MRI.
2.6. Cytotoxicity assay
Cell viability and proliferation were analyzed by the MTT
colorimetric assay21 using Vero cells (monkey kidney epithelial
cells) cultured in Dulbecco’s Modified Eagle’s Medium
(DMEM), supplemented with 10% fetal bovine serum (FBS),
5% glutamine and 5% penicillin/streptomycin. Cell cultures
were incubated at 37 °C under a 5% CO2 atmosphere. For the
cytotoxicity assay 1 × 104 cells were seeded in each well of 96-
well plates and cultured for 24 h. After 24 h, the medium was
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replaced with a fresh medium containing the diﬀerent types of
nanoparticles in varying concentrations. After cultivation again
for 24 h, the cells were thoroughly washed with DPBS and
20 µL of MTT dye solution (5 mg mL−1 in PBS) was added to
each well. Following 4 h of incubation at 37 °C, formazan crys-
tals were dissolved with 200 µL of DMSO. The absorbance of
each well was determined on a microplate reader (Thermo
Scientific Multiskan GO UV/Vis microplate spectrophotometer)
at λ = 740 nm. The spectrophotometer was calibrated to zero
absorbance using a culture medium without cells. The relative
cell viability (%) related to control wells containing a cell
culture medium without nanoparticles was calculated by [A]
test/[A]control × 100. Each measurement was repeated at least
five times to obtain the mean values and the standard
deviation.
3. Results and discussion
3.1. Undoped NaGd(MoO4)2 nanoparticles
It has been well documented that homogeneous precipitation
is a suitable procedure for the formation of uniform particles
in solution. Such a homogeneous process can be achieved by a
controlled release of anions or cations, so that the kinetics of
precipitation is similar throughout the solution.22 In our case,
we have selected the controlled release of Gd3+ cations through
the formation of a Ln3+–Cit3− complex in the initial solution,
which can be thermally decomposed slowly releasing the Ln3+
cations involved in the formation of the solid phase.23 It is
also known that to obtain uniform particles by these pro-
cedures, a specific kinetic of precipitation is required, which
must be found through an appropriate adjustment of the
experimental parameters (reagent concentrations, temperature
and nature of solvent). In our case, this task was first
addressed for the undoped NaGd(MoO4)2 system, for simpli-
city. The results of this study are summarized in Table 1.
In this table, it can be observed that the formation of
uniform particles only took place under a very restrictive set of
conditions. In particular, uniform nanoparticles with ellipsoi-
dal shape (Fig. 1a) and narrow size distribution (120 ± 10 × 60
± 6 nm, Table 1) were obtained by aging at 120 °C for 20 h, a
0.02 mol dm−3 Gd(III) and 0.1 mol dm−3 Na2MoO4 (MoO4
2−/
Gd3+ ratio = 5) solution having citrate ions (citrate/Gd3+ mol
ratio = 2) in an EG : H2O mixture (volumetric ratio 4 : 1). The
formation of the Gd3+–citrate complex is essential for the for-
mation of uniform particles since in the absence of citrate,
heterogeneous ovoids with a certain degree of aggregation
were obtained (Fig. S1a in the ESI†). This was the expected
result, since without the formation of the Gd–citrate complex,
the controlled release of cations into solution does not take
place, not achieving the conditions required for homogeneous
precipitation. The amount of citrate anions added is also criti-
cal since for a large excess of citrate ions (citrate/Gd3+ mol
ratio = 5), no appreciable precipitation was detected, indicating
that the decomposition of the Ln–citrate complex does not
occur or that the kinetics of precipitation is very low under
these conditions. On the other hand, when the citrate/Gd3+
mol ratio was diminished from 2 to 1, aggregated and more
heterogeneous particles were obtained (Fig. S1b†), which
suggests that such an amount of citrate is insuﬃcient to
achieve a complete chelating interaction between the citrate
and rare-earth ions resulting in a heterogeneous kinetic of
precipitation.
Another factor that plays a decisive role in the formation of
uniform ellipsoidal nanoparticles is the presence of water in
the reaction medium. Thus, when using pure EG as a solvent,
no appreciable precipitation was observed (Table 1). This be-
havior may be ascribed to the high viscosity of the solvent that
slows down the diﬀusion processes implicated in the solid
Fig. 1 TEM images of the nanoparticles obtained under the following
experimental conditions: (a) MoO4
2−/Gd3+ mol ratio = 5 ([Gd(III)] = 0.02
M, [Na2MoO4] = 0.1 M); (b) volumetric ratio EG : H2O (3.5 : 1.5) and (c)
MoO4
2−/Gd3+ mol ratio = 2 ([Gd(III)] = 0.05 M, [Na2MoO4] = 0.1 M). In all
cases the temperature and the mol ratio citrate/Gd3+ remained constant
as described in Table 1.
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phase formation and particle growth. In agreement with this
interpretation would be the increase of the particle size from
120 × 60 nm to 265 × 140 nm observed when the EG : water
volumetric ratio was reduced from 4 : 1 to 3.5 : 1.5 (Table 1,
Fig. 1b), which involves a decrease of viscosity.
The formation of uniform ellipsoids also occurs within a
narrow range of precursor concentrations in the starting solu-
tions. Thus, by decreasing the concentration of Gd(III) from
0.02 mol dm−3 to 0.01 mol dm−3 (keeping constant the
MoO4
2−/Gd3+ ratio and the other synthesis parameters), pre-
cipitation was not detected indicating that the minimum con-
centration for nucleation was not achieved, while by increasing
such a magnitude from 0.02 mol dm−3 to 0.04 mol dm−3,
heterogeneous particles were obtained (Fig. S1c†). In the latter
case, due to the high concentration of precursors, several
nucleation events may take place, which would lead to hetero-
geneous systems, according to the classical model proposed by
LaMer and Dinegar.24 Moreover, it was observed that with the
increase of the temperature to 150 °C, heterogeneous particles
were obtained (Fig. S1d†), whereas when the temperature was
lowered to 80 °C no appreciable precipitation was observed
(Table 1). These changes observed when varying the synthesis
temperature must also be ascribed to variations in the kinetics
of precipitation, which aﬀect the nucleation and growth
processes.
Finally, the eﬀects of the MoO4
2−/Gd3+ mol ratio on the pre-
cipitation process were also investigated. It was found that
keeping constant all the conditions required to obtain the par-
ticles shown in Fig. 1a, but reducing such a mol ratio from
5 to 2 by increasing the amount of Gd3+ from 0.02 to 0.05 mol
dm−3, a significant decrease in the mean particle size from
120 × 60 nm to 70 × 35 nm was observed (Table 1), keeping the
same morphology (Fig. 1c). However and surprisingly, no pre-
cipitation was detected for the same value of the MoO4
2−/Gd3+
mol ratio (2) when it was achieved by reducing the amount of
molybdate ions from 0.1 to 0.04 mol dm−3. It should be noted
that the total amount of Na+ ions present in the solution
(coming from both molybdate and citrate precursors) is much
lower in the latter case (0.2 mol dm−3) than in the other experi-
ments conducted with uniform ellipsoids (≥0.32 mol dm−3).
This observation seems to suggest that the precipitation of the
NaGdMoO4 phase under the studied conditions also requires a
large excess of Na+ ions in the initial solutions.
According to XRD, all samples consisting of uniform ellip-
soids were crystalline, having a tetragonal NaGd(MoO4)2 struc-
ture (ICDD file: 25-0828), as illustrated in Fig. 2 for the
smallest particles (Fig. 1c).
3.2. Ln-doped NaGd(MoO4)2 nanoparticles
In order to synthesize Eu-doped nanophosphors, we addressed
the doping of the NaGd(MoO4)2 nanoparticles with Eu
3+
cations using the conditions involved in the synthesis of the
sample shown in Fig. 1c composed by the smallest particles
here obtained (70 × 35 nm, Table 1), which are more appropri-
ate for bioapplications. For doping, the total Ln concentration
(0.05 mol dm−3) was kept constant, whereas the doping level
was varied between 2 and 15% (Eu/Eu + Gd mol ratio) in order
to optimize the luminescent properties of these
nanophosphors.
It was found that the addition of Eu to the starting solu-
tions did not produce noticeable changes in the morphologi-
cal characteristics of the precipitated nanoparticles whose
shape and size were similar to those obtained for the undoped
systems (Fig. S2†). The XRD patterns of the doped samples
(Fig. S3 in the ESI†) were also similar to that of undoped NaGd
(MoO4)2, indicating that they also crystallized in the tetragonal
phase.
The success of the doping procedure was confirmed by ICP
analyses, which showed that the experimental Eu/(Eu + Gd)
ratio obtained for all doped samples was very similar to the
nominal values (Table 2).
FTIR analyses gave additional information on the compo-
sition of the doped nanoellipsoids. Thus, as shown for the
Eu(5%):NaGd(MoO4)2 nanoparticles, their infrared spectrum
(Fig. 3) displayed bands corresponding to the absorbed water
(3400 and 1630 cm−1) and to the Mo–O stretching vibration of
the MoO4
2− anion (<1000 cm−1)25 along with some other
bands (1590–1400 cm−1 region), which can be associated with
the carboxylate groups coming from the adsorbed citrate
Fig. 2 X-ray diﬀraction patterns obtained for the nanoparticles shown
in Fig. 1c. The reference pattern corresponding to the tetragonal phase
of NaGd(MoO4)2 is also included.
Table 2 Nominal and experimental (ICP) Eu/(Eu + Gd) mol ratio of the
Eu doped-NaGd(MoO4)2@citrate samples
Eu/(Eu + Gd)
Nominal [%] ICP [%]
2 2.05
5 5.5
10 10.8
15 15.2
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ions.26 Therefore, the method of synthesis developed in this
work produces uniform NaGd(MoO4)2 nanoparticles coated
with citrate ions, which hereafter will be labeled as NaGd
(MoO4)2@citrate. Thermogravimetric analyses performed for
these nanoparticles (Fig. 4) gave an estimation on the extent of
coating. Thus, a weight loss of ∼5 wt% was observed in the
temperature range of 25–250 °C, due to the elimination of
absorbed water, whereas an additional weight loss of ∼4.5 wt%
took place at higher temperatures (250–800 °C), which can be
associated with the decomposition of the adsorbed citrate ions.
The photoluminescent properties of Eu:NaGd
(MoO4)2@citrate nanoparticles are displayed in Fig. 5. The
excitation spectrum recorded for the nanoparticles with a Eu
content of 5%, monitored at the most intense Eu3+ emission
band (614 nm), is presented in Fig. 5a. As is observed, this
spectrum displayed a strong broad band whose maximum
intensity lies beyond the detection limit of our spectrofluori-
meter (∼250 nm). This feature has been reported to corres-
pond to an energy transfer (ET) process from the excited levels
of the MoO4
2− group to the Eu3+ cations.21 The bands resulting
from the direct excitation of Eu3+ (the most intense being that
appearing at 393 nm, which is due to the f–f electronic tran-
sition characteristics of the Eu3+ ions),27 were also found (inset
in Fig. 5a), although they were much weaker.
Upon excitation within the ET band (λex = 250 nm), the
emission band characteristics of the electronic transitions
from the 5D1 to
7F1 (535 nm) and from the
5D0 to the
7FJ ( J = 1,
2, 3, and 4) levels of Eu3+ (λem > 550 nm) were detected
(Fig. 5b). It is well known that the relative intensities of
5D0–
7F2 (614 nm) and
5D0–
7F1 (593 nm) transitions strongly
depend on the local symmetry of the Eu3+ ions, since the latter
transition is magnetic-dipole allowed and insensitive to the
local environment of the Eu(III) cations, whereas the 5D0–
7F2
electric-dipole transition becomes the strongest one when the
Eu local symmetry is lowered.28 In our case, the emission origi-
nating from the 5D0–
7F2 transition is clearly dominant, indicat-
ing that the Eu3+ occupies a crystallographic site in the host
lattice with no inversion center.18 The much higher intensity
of the 5D0–
7F2 transition when compared with the one of the
other bands gives rise to a visible red emission with high color
purity, as is illustrated in the inset of Fig. 5b.
In Fig. 5b, it can also be observed that the emission inten-
sity observed after excitation through the ET band was much
higher than that corresponding to the direct excitation of Eu3+
cations (393 nm), indicating that the former excitation path is
more favorable.
To study the eﬀects of the Eu content on the luminescence
of the Eu–NaGd(MoO4)2@citrate samples, they were excited
through the energy transfer band (λex = 250 nm). In Fig. 5c, it
can be observed that the increase of the Eu doping level from
2% to 5% gave rise to an important increase of the intensity of
the emission bands as a consequence of the increase in the
number of emission centers. However, such intensity decreased
significantly when the Eu content was increased to 10%
suggesting the presence of a concentration quenching eﬀect.
In order to gain more information on the luminescence
eﬃciency of these samples, lifetime measurements were also
carried out. The decay curves obtained for the 5D0 →
7F2 tran-
sition (614 nm), after pulsed excitation at λex = 532 nm, as a
function of the Eu concentration are shown in Fig. 5d. Under
these conditions, the Eu3+ ions are excited to the 5D1 multiplet,
and then they decay partially non-radiatively to the 5D0 level,
from where the emissions to the lower 5FJ ground state multi-
plets are observed.29 In all cases, the decays are not single
exponentials, but can be fitted by using a bi-exponential tem-
poral dependence according to eqn (1):
IðtÞ ¼ I01 expðt=τ1Þ þ I02 expðt=τ2Þ ð1Þ
where I(t ) is the luminescence intensity, t is the time after exci-
tation, and τi (i = 1, 2) is the decay time of the i component,
Fig. 3 Infrared spectra obtained for the Eu doped-NaGd(MoO4)2 nano-
particles before and after functionalization with PLL. The infrared spec-
trum of sodium citrate and PLL are also included for comparison.
Fig. 4 TGA curves obtained for the NaGd(MoO4)2 nanoparticles before
and after functionalization with PLL.
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with intensity I0i. The results are presented in Fig. S4,† and the
corresponding fitting parameters are summarized in Table 3.
As is observed, the long-time component (I02) is dominant
(about 70%) for all samples. This component is widely
accepted to correspond to the decay time of the active ions
located in the nanoparticle bulk, and therefore not aﬀected by
the surface eﬀects.30 The shorter component (I01) is usually
associated with the decay of rare active ions near the surface,
whose luminescence is quenched through multiphononic pro-
cesses associated with the presence of impurities and solvent
molecules.31,32 In our case, such quenchers must be the citrate
anions and water molecules adsorbed on the nanoparticles as
detected by FTIR and TGA measurements, which present high
vibrational energies.
Considering the non-exponential character of the decay
curves, they are usually33 characterized by an average decay
time, defined as hτi ¼
Ð
tIðtÞdt
Ð
IðtÞdt , which in the case of a bi-expo-
nential behaviour becomes:
hτi ¼ I01τ1
2 þ I02τ22
I01τ1 þ I02τ2 ð2Þ
Fig. 5 (A) Excitation spectrum (λem = 614 nm) of the citrate coated-Eu(5%):NaGd(MoO4)2 nanoparticles. Inset in (A) magniﬁcation of the
350–480 nm region for a better visualization of the electronic transitions corresponding to the 4f 6 conﬁguration of Eu3+ ions. (B) Emission spectra
recorded for the same nanoparticles using diﬀerent excitation wavelengths. Inset in (B) photograph of the nanoparticles in water suspension taken
under UV illumination at λ = 312 nm. (C) Emission spectra (λexc = 250 nm) of the Eu-doped NaGd(MoO4)2@citrate nanoparticles with a diﬀerent Eu
content; and (D) temporal evolution of the 5D0 →
7F2 luminescence (614 nm) for the NaGd(MoO4)2@citrate nanoparticles with increasing amounts
of Eu3+ (excitation at 532 nm).
Table 3 Lifetimes values (τ1, τ2) and average decay time (<τ>) for the Eu
doped-NaGd(MoO4)2@citrate nanoparticles obtained for the
5D0 →
7F2
transition (615 nm) after pulsed excitation (λex = 532 nm) as a function of
the Eu content and ﬁtted as the superposition of two components with
initial amplitudes I01 (short) and I02 (long). The relative experimental
error was estimated to be 5%
Eu/(Eu + Gd) nominal [%] I01 τ1 (ms) I02 τ2 (ms) <τ> (ms)
2 0.35 0.33 0.65 0.80 0.70
5 0.40 0.48 0.60 0.93 0.79
10 0.30 0.24 0.70 0.66 0.59
15 0.29 0.17 0.71 0.52 0.47
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These average values, calculated using the latter equation from
the corresponding fitting parameters, have also been included
in Table 3.
As is observed, these values are dependent on the Eu con-
centration, the sample with an Eu content of 5% showing the
higher average lifetime value (τ = 0.79 ± 0.04 ms), which is in
agreement with the optimum doping level suggested by the
emission spectra. For Eu concentrations above 5%, the average
lifetime values experienced a reduction (Table 3), indicating
that at these doping levels concentration quenching becomes
operative by the increase of the amount of luminescent
centers. As is shown in Fig. S5,† the concentration dependence
of the lifetime can be fitted considering a lifetime reduction
from the low concentration value (τ0) due to a quenching term,
Wq, proportional to the square of Eu concentration:
1
τ
 1
τ0
¼ Wq ¼ V ½Eu2, a characteristic dependence also found
in other materials.34,35 It must be mentioned that the lifetime
values obtained for our optimum sample is much higher than
those reported in the literature for tetragonal Eu:NaGd(MoO4)2
phosphors (≤0.47 ms),23,36,37 which might suggest the higher
luminescence eﬃciency of our nanophosphors.
For further studies, we selected the sample with the stron-
gest emission, which was that with a europium doping level
of 5%.
The longitudinal (r1) and transversal (r2) relaxivity values
for the Eu(5%):NaGd(MoO4)2@citrate nanoparticles were
measured to evaluate their potential application as an MRI
contrast agent. It is well known that the transverse relaxivity
(r2) to longitudinal relaxivity (r1) ratio governs the ability of a
contrast agent to be used as negative (MRI images become
darker on increasing the nanoparticle concentration) or posi-
tive (MRI images become brighter on increasing the nano-
particle concentration) agents, the latter being preferred since
they permit diminishing the possible interferences with other
pathogenic or biological signals.38 Thus, a low r2/r1 ratio (<5) is
considered to be ideal for positive MRI contrast agents.39 As is
observed in Fig. 6, the r1 value obtained for the Eu(5%):NaGd
(MoO4)2@citrate sample at 1.5 T was very high (8.96 mM
−1
s−1), whereas r2 was 5.03 mM
−1 s−1, resulting in an r2/r1 ratio
of 1.78, which is among the lowest values ever reported for Gd
containing nanoparticles5,16,40 making our system appropriate
as a positive MRI contrast agent.
Biocompatibility studies were performed by evaluating the
cell viability using Vero cells through the MTT assay.21 The
metabolic activity and proliferation of fibroblasts were
measured after 24 hour culture and the results are shown in
Fig. 7. In this figure, it can be seen that the Eu(5%):NaGd
(MoO4)2@citrate nanoparticles showed negligible toxicity
eﬀects with viability percentages as high as >90% for concen-
trations up to 0.2 mg mL−1.
The colloidal stability of these nanoparticles was also evalu-
ated to assess their suitability for biotechnological appli-
cations. It was observed that the hydrodynamic diameter (dh)
obtained from the DLS measurements conducted on water sus-
pensions (pH = 6.8) was only slightly higher (77 nm) than the
mean particle size obtained from the TEM pictures (70 ×
35 nm), which indicates that the nanoparticles can be well dis-
persed in water (Fig. 8). However, in MES physiological buﬀer
(50 mM, pH = 6.5), the value of the hydrodynamic diameter
(Fig. 8) was clearly much higher (477 nm), which clearly indi-
cates the presence of an aggregation process, suggesting that
the citrate coating is insuﬃcient to achieve colloidal stability
in such a medium.
3.3. PLL-functionalization of Eu:NaGd(MoO4)2@citrate
nanoparticles
To improve the colloidal stability of our Eu:NaGd
(MoO4)2@citrate nanoparticles in physiological buﬀer, they
were further functionalized with PLL even under sterile con-
ditions. Owing to the presence of positive charges in PLL
coming from the amino groups, it is expected that the mole-
cular chains bind the particle surface by means of attractive
electrostatic forces between such groups and the carboxylate
Fig. 6 Proton relaxivities (r1 and r2) of the citrate coated-Eu(5%) : NaGd
(MoO4)2 nanoparticles (top) and for the same nanoparticles functiona-
lized with PLL (bottom), both measured at 1.5 T.
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groups (negatively charged) coming from the citrate anions
present on the surface of the pristine nanoparticles.41
Information on the PLL functionalization process was
obtained from the zeta potential measurements conducted for
aqueous suspensions at pH = 6.8. Thus, the zeta potential of
the NaGd(MoO4)2@citrate nanoparticles was −39 mV, whereas
the value of this magnitude after the treatment with PLL was
+29.6 mV. This surface charge reversal clearly suggests the
success of such a functionalization process.
The presence of PLL on the surface of the nanoparticles
was also substantiated by FTIR spectroscopy. Thus, in addition
to the vibrational features due to the non-functionalized nano-
particles, the FTIR spectrum obtained for the PLL-functiona-
lized nanoparticles (Fig. 3) displayed some extra signals that
confirm the presence of PLL on the surface of the nano-
particles. In particular, the amide I band due to the CvO
group stretching mode and the amide II band resulting from
C–N stretching and N–H bending modes were observed at
1647 cm−1 and 1542 cm−1, respectively.8,9
Thermogravimetric analyses were performed to estimate
the amount of PLL species attached to the nanoparticle
surface. The TGA curve obtained for the PLL-functionalized
nanoparticles is shown in Fig. 4. As is observed, the total mass
loss was higher (∼30.5 wt%) than that observed for the pristine
citrate coated nanoparticles (∼9.5 wt%). In both cases two
steps were detected, which occurred at the same temperature
range. The first one (25–250 °C), due to the water release, was
slightly higher (∼6.5 wt%) for the PLL coated nanoparticles
than that observed before PLL functionalization (∼5 wt%). The
second loss took place at 250–800 °C and must be ascribed to
the decomposition of the adsorbed organic species, PLL and
citrate anions. Such a loss was also much higher after
(∼24 wt%) than before (4.5%) PLL coating. Therefore, it can be
considered that the amount of PLL species on the surface of
the nanoparticles should correspond to an ∼19.5 wt%.
The functionalization with PLL had a positive eﬀect on the
colloidal stability of the here synthesized nanophosphors.
Thus, the mean hydrodynamic diameter obtained for the
Fig. 7 Cytotoxicity proﬁles for Vero cells of the citrate coated-Eu
(5%) : NaGd(MoO4)2 nanoparticles (top) and for those further functiona-
lized with PLL (bottom), determined by MTT assay. Percentage of viabi-
lity of cells was expressed relative to control cells (n = 5). Results are
represented as mean ± standard deviations.
Fig. 8 Hydrodynamic diameter (dh) obtained from the DLS measure-
ments in Milli-Q water at pH = 6.8 and in biological buﬀer media (MES at
pH = 6.5) for the citrate coated-nanoparticles (top) and for the PLL-
functionalized nanoparticles (bottom).
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Eu:NaGd(MoO4)2@citrate@PLL nanoparticles from the DLS
measurements in water (Fig. 8) was only slightly higher
(160 nm) than that obtained for the citrate-coated
NaGd(MoO4)2 system (77 nm), which can be explained by the
existence of PLL on the nanoparticle surface, although the pres-
ence of a weak aggregation process cannot be discarded. The
colloidal stability of this sample in MES buﬀer was also evalu-
ated. It was found that the average hydrodynamic diameter of
the PLL-functionalized nanoparticles remained unaltered
(155 nm) when compared with the value obtained for freshly
prepared dispersions in Milli-Q water at pH = 6.8 (160 nm), indi-
cating the absence of significant aggregation also in MES
buﬀer, and therefore, a high colloidal stability of the PLL-func-
tionalized nanoparticles in this medium. Therefore, only after
PLL functionalization, the Eu:NaGd(MoO4)2@citrate nano-
particles meet the criterion of colloidal stability required for
their use in biotechnological applications.
It is important to mention that the functionalization with
PLL did not aﬀect in a significant manner the photo-
luminescence properties of the nanophosphors. Thus, the inten-
sity of the emission bands (λex = 250 nm) of the PLL-
functionalized sample was only slightly lower than that observed
before functionalization (Fig. S6†), which indicates that the pres-
ence of PLL molecules on the surface of the nanoparticles
already coated with citrate ions, did not increase the Eu3+ lumine-
scence quenching due to the interaction of these ions with the
organic species. Therefore, these PLL-modified Eu:NaGd
(MoO4)2@citrate nanoparticles maintain a red luminescence and
may be used as optical biolabels for “in vitro” applications.
Biocompatibility studies of these nanophosphors were also
evaluated finding a slight increase of toxicity after PLL
functionalization (Fig. 7), which might be due to the positive
surface charge of the PLL-functionalized nanoparticles, as pre-
viously noticed for various types of nanoparticles.42,43
Nevertheless, viability percentages of around 80% were still
obtained for concentrations up to 0.025 mg ml−1 (Fig. 7),
which are suitable for their use as MRI contrast agents.
Finally, it was also found that the r1 value decreased (from
5.03 to 2.12 mM−1 s−1) after PLL functionalization, whereas
the r2 value remained almost unchanged (8.7 mM
−1 s−1)
(Fig. 6) which gives an r2/r1 ratio of 4.10, indicating that the
PLL-functionalized nanoparticles are more suitable as a nega-
tive MRI contrast agent. It should be noted that external
organic surface coating has been previously shown to have an
important eﬀect on the magnetic relaxivities of particulate
MRI contrast agents, since it would impact the access of water
molecules to the superficial Gd3+ ions.44 Nevertheless, in our
case the r2/r1 ratio was suﬃciently low for the nanoparticles to
be suitable as a positive MRI contrast agent.
The magnetic relaxivities obtained for the nanoparticles at
a high magnetic field (9.4 T) were diﬀerent (r1 = 1.35 mM
−1 s−1
and r2 = 96.42 mM
−1 s−1) to those measured at a low magnetic
field (1.5 T), giving an r2/r1 ratio of 71.42. This very high value
indicates that these nanoparticles will behave as a T2 rather
than T1 contrast agent when using preclinical magnetic fields,
as illustrated in Fig. 9 and 10.
Fig. 9 T1 and T2 relaxivities of PLL-functionalized nanoparticles
measured at 9.4 T.
Fig. 10 T1-Weighted (a) and T2-weighted (b) MR images of phantoms
containing solutions of PLL-functionalized nanoparticles at concen-
trations ranging from 0.01 mM (top, left) to 0.2 mM (right, down).
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4. Conclusions
Uniform NaGd(MoO4)2 nanoparticles have been synthesized
for the first time through a homogeneous precipitation
method at a relatively low temperature (120 °C) using a citrate–
Gd complex as a Gd precursor and ethylene glycol/water mix-
tures as solvent. This procedure yields nanoparticles with an
ellipsoidal morphology and a tetragonal structure, which
resulted in coating with citrate anions during the synthesis
process. These nanoparticles could be doped with Eu cations
without altering their morphology or crystalline structure. The
Eu doped samples presented a red luminescence when excited
through an energy transfer band from the MoO4
2− group to
the Eu3+ centers. The maximum luminescence eﬃciency was
achieved for a 5% doping level. These nanophosphors showed
no significant toxicity for cells up to a concentration of
0.2 mg mL−1 and also presented appropriate magnetic relaxiv-
ity values (low r2/r1 ratio) for their use as a positive MRI con-
trast agent at a low magnetic field (1.5 T). The colloidal
stability of such nanoparticles in a physiological (MES)
medium was achieved after their functionalization with
poly(L-lysine). It was found that the so functionalized nano-
particles maintained a visible red luminescence and cell viabi-
lity at concentrations up to 0.025 mg mL−1. Finally, magnetic
relaxivity measurements revealed a significant increase of the
r2/r1 ratio after functionalization so that the poly(L-lysine)-func-
tionalized nanoparticles were more suitable as a negative con-
trast agent for MRI, even at high magnetic fields similar to
those used in preclinical tests. Therefore, the here reported
multifunctional nanoparticles meet the main requirements to
be good candidates for their use in optical (in vitro) and mag-
netic imaging applications.
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